Gyre Therapeutics, Inc. (GYRE)
NASDAQ: GYRE · Real-Time Price · USD
7.40
-0.17 (-2.25%)
At close: Jan 9, 2026, 4:00 PM EST
7.38
-0.02 (-0.27%)
After-hours: Jan 9, 2026, 7:05 PM EST
Gyre Therapeutics Market Cap
Gyre Therapeutics has a market cap or net worth of $672.59 million as of January 9, 2026. Its market cap has decreased by -35.76% in one year.
Market Cap
672.59M
Enterprise Value
613.70M
1-Year Change
-35.76%
Ranking
Category
Stock Price
$7.40
Market Cap Chart
Since October 31, 2023, Gyre Therapeutics's market cap has increased from $515.41M to $672.59M, an increase of 30.50%. That is a compound annual growth rate of 12.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 672.59M | 4.82% |
| Dec 31, 2025 | 641.69M | -38.21% |
| Dec 31, 2024 | 1.04B | -47.22% |
| Dec 29, 2023 | 1.97B | 281.72% |
| Oct 31, 2023 | 515.41M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 952.29B |
| Johnson & Johnson | 492.44B |
| AbbVie | 388.97B |
| UnitedHealth Group | 311.59B |
| AstraZeneca | 295.57B |
| Merck & Co. | 274.34B |
| Novartis AG | 272.98B |
| Novo Nordisk | 263.81B |